期刊文献+

晚期胃癌不同化学治疗方案的疗效比较 被引量:2

Effect of different chemotherapy regimen for advanced gastric carcinoma
原文传递
导出
摘要 目的观察泰素+氟尿嘧啶(TF)方案和草酸铂+四氢叶酸钙+脱氧氟尿苷(OLD)方案治疗晚期胃癌的近期疗效。方法将经病理检查证实为晚期胃癌的患者117例随机分为TF组(51例)和OLD组(66例)。28d为1个化疗周期,至少接受2个化疗周期。结果TF组初治病例有效率为62.5%,复治病例有效率为59.3%,总有效率为60.8%;OLD组分别为54.8%,31.4%,42.4%。两组初治病例有效率比较差异无显著性(P>0.05),复治病例有效率及总有效率比较差异均有显著性(均为P<0.05)。TF组中位无进展时间8.7个月、中位生存时间19个月;OLD组分别为7.6个月和17.8个月;两组比较差异均无显著性(均为P>0.05)。毒副反应以骨髓抑制和周围神经炎为主,TF组的发生率显著高于OLD组(P<0.05)。结论TF方案和OLD方案治疗晚期胃癌均有较好的近期疗效,患者耐受性好,而后者的毒副反应更轻,临床应用更安全。 Objective To compare the short-term efficacy of TF ( Taxol + 5-fluorouracil) and OLD { Oxaliplatin +5'-DFUR + LV ) in the treatment of advanced gastric carcinoma. Methods 117 gastric carcinoma patients confirmed pathalogically were randomized into TF group ( n = 51 ) and OLD group ( n = 66 ). 28 days was taken as a chemotherapy courses. All patients received at least two courses of chemotherapy. Results The effective rate was 62.5 % in initial treatment of TF group and 59.3% in the retreatment of TF group, respectively, with overall effective rate of 60.8% and which were 54.8% and 31.4% ,respectively,with overall effective rate of 42.4% in OLD group. There was no significant difference in the effective rate of initial treatment case between the two groups ( P 〉 0.05 ), but there was significant difference in the effective rates of retreatment group and overall effective rates between groups ( P 〈 0.05 for each ). The median time to progression ( TIP ) and the median survival time were 8.7 months and 19 months, respectively in TF group,whereas which were 7.6 months and 17.8 month in OLD group, respectively,with no significant difference between the groups (P 〉 0.05 ). Toxic and side effects mainly bone marrow depression and peripheral neuritis, which incidences were higher in TF group than in OLD group (P 〈 0.05 ). Conclusion Both TF and OLD regimen have better short-term effects and well tolerated but the latter has more slighter side effects and is safer clincially.
出处 《中国综合临床》 北大核心 2005年第12期1121-1123,共3页 Clinical Medicine of China
关键词 晚期胃癌 泰素 氟尿嘧啶 草酸铂 脱氧氟尿苷 Advanced gastric carcinoma Taxon 5-fluorouracil Oxaliplatin 5'-DFUR
  • 相关文献

参考文献8

  • 1Louvet C,Andre T,Tigaud JM,et al.Phase Ⅱ study of oxaliplatin,fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients[J].J Clin Oncol,2002,20(23):4 543-4 548.
  • 2Yamada Y,Shirao K,Ohtsu A,et al.Phase II trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions[J].Ann Oncol,2001,12(8):1 133-1 137.
  • 3Kim YH,Shin SW,Kim BS,et al.Paclitaxel, 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma[J].Cancer,1999,85(2):295-301.
  • 4Kollmannsberger C,Quietzsch D,Haag C,et al.A phase II study of paclitaxel,weekly,24-hour continous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer[J].Br J Cancer,2000,83(4):458-462.
  • 5Murad AM,Petroianu A,Guimaraes RC,et al.Phase II trial of the combination of paclitaxel and 5-fluorouracil in the treatment of advanced gastric cancer: a novel,safe,and effective regimen[J].Am J Clin Oncol,1999, 22(6):580-586.
  • 6沈琳,杨伯琴,李洁,李燕,高宇,金懋林.5'-DFUR(氟铁龙)联合化疗方案治疗进展期胃癌[J].中华消化杂志,1998,18(3):177-178. 被引量:5
  • 7贡东卫,叶古祥,陈亚军.氟尿苷联用化疗药物对胃癌细胞株的抑制作用观察[J].中国基层医药,2004,11(11):1308-1309. 被引量:1
  • 8徐千朗,吉学源,戴圣斌.羟基喜树碱、依托泊苷、5-氟尿嘧啶联合治疗老年人晚期胃癌40例[J].中国癌症杂志,2000,10(3):237-238. 被引量:7

二级参考文献6

共引文献9

同被引文献11

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部